Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Antonuzzo · SciRah

Researcher profile · Semantic Scholar

A. Antonuzzo

Share profile

A. Antonuzzo — researcher profile on SciRah

h-index: 24
Works: 146
Citations: 2,150

Most-cited papers

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines.
P. Bossi, A. Antonuzzo, N. Cherny, O. Rosengarten +6 more
2018Annals of Oncology141 citations Open access
Semantic Scholar
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
P. Queirolo, F. Spagnolo, P. Ascierto, E. Simeone +14 more
2014Journal of Neuro-Oncology118 citations Open access
Semantic Scholar
Interprofessional spiritual care in oncology: a literature review
C. Puchalski, A. Sbrana, B. Ferrell, Najmeh Jafari +10 more
2019ESMO Open109 citations Open access
Semantic Scholar
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
A. Fontana, L. Galli, A. Fioravanti, P. Orlandi +12 more
2009Clinical Cancer Research89 citations Open access
Semantic Scholar
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors
F. Spada, L. Antonuzzo, R. Marconcini, D. Radice +13 more
2016Neuroendocrinology83 citations Open access
Semantic Scholar
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
F. Roila, G. Fumi, B. Ruggeri, A. Antonuzzo +16 more
2018Supportive Care in Cancer59 citations
Semantic Scholar
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months
R. Marconcini, L. Galli, A. Antonuzzo, S. Bursi +4 more
2017Experimental Hematology & Oncology42 citations Open access
Semantic Scholar
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
E. Vasile, G. Masi, L. Fornaro, S. Cupini +11 more
2009British Journal of Cancer37 citations Open access
Semantic Scholar
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients
L. Derosa, L. Galli, P. Orlandi, A. Fioravanti +10 more
2014Cancer35 citations Open access
Semantic Scholar
Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist’s interdisciplinary position paper
S. Rauh, A. Antonuzzo, P. Bossi, R. Eckert +7 more
2018ESMO Open32 citations Open access
Semantic Scholar
Fatigue, a major still underestimated issue
C. Ripamonti, A. Antonuzzo, P. Bossi, S. Cavalieri +2 more
2018Current Opinion in Oncology31 citations
Semantic Scholar
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care
A. Antonuzzo, E. Vasile, A. Sbrana, Maurizio Lucchesi +8 more
2016Supportive Care in Cancer26 citations
Semantic Scholar
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
E. Giommoni, R. Giorgione, A. Paderi, E. Pellegrini +9 more
2021Immuno25 citations Open access
Semantic Scholar
Practical issues for the management of hyponatremia in oncology
R. Berardi, A. Antonuzzo, L. Blasi, R. Buosi +6 more
2018Endocrine22 citations
Semantic Scholar
Developing drugs in cancer-related bone pain.
M. Lucchesi, G. Lanzetta, A. Antonuzzo, A. Rozzi +5 more
2017Critical reviews in oncology/hematology22 citations
Semantic Scholar
Use of procalcitonin in clinical oncology: a literature review.
A. Sbrana, M. Torchio, G. Comolli, A. Antonuzzo +1 more
2016The New Microbiologica22 citations
Semantic Scholar
The hospital care of patients with cancer: a retrospective analysis of the characteristics of their hospital stay in comparison with other medical conditions.
G. Numico, C. Zanelli, R. Ippoliti, M. Rossi +3 more
2020European Journal of Cancer20 citations
Semantic Scholar
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions
E. Sammarco, Fiorella Manfredi, A. Nuzzo, M. Ferrari +6 more
2023Cancers18 citations Open access
Semantic Scholar
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
L. Fornaro, G. Masi, S. Bursi, F. Loupakis +8 more
2009Cancer Chemotherapy and Pharmacology17 citations
Semantic Scholar
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy.
P. Bossi, L. Botta, P. Bironzo, C. Sonetto +6 more
2016Future Oncology16 citations Open access
Semantic Scholar
The role of automated cytometry in the new era of cancer immunotherapy.
M. Danova, M. Torchio, G. Comolli, A. Sbrana +2 more
2018Molecular and clinical oncology15 citations Open access
Semantic Scholar
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey
S. Carnio, D. Galetta, V. Scotti, D. Cortinovis +17 more
2018Supportive Care in Cancer14 citations Open access
Semantic Scholar
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)
A. Tralongo, A. Antonuzzo, P. Pronzato, A. Sbrana +3 more
2020Tumori13 citations
Semantic Scholar
Use of procalcitonin in clinical oncology: a literature review.
A. Sbrana, M. Torchio, G. Comolli, A. Antonuzzo +1 more
2016The New Microbiologica13 citations
Semantic Scholar
Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
C. Tibaldi, E. Mazzoni, G. Arcabasso, A. D’Incecco +3 more
2009Clinical Lung Cancer12 citations
Semantic Scholar
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
A. Antonuzzo, C. Ripamonti, F. Roila, A. Sbrana +19 more
2022Frontiers in Oncology11 citations Open access
Semantic Scholar
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact
P. Bossi, M. Lucchesi, A. Antonuzzo
2015Current Opinion in Supportive and Palliative Care11 citations
Semantic Scholar
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapy.
A. Sbrana, Rachele Antognoli, G. Pasqualetti, G. Linsalata +7 more
2020Journal of Geriatric Oncology9 citations
Semantic Scholar
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
P. Bossi, M. Airoldi, M. A. Aloe Spiriti, A. Antonuzzo +6 more
2020Expert Opinion on Drug Safety8 citations Open access
Semantic Scholar
Small-Bowel Neuroendocrine Tumor and Retroperitoneal Fibrosis: Efficacy of Octreotide and Tamoxifen
E. Biasco, A. Antonuzzo, L. Galli, G. Baldi +5 more
2015Tumori8 citations
Semantic Scholar
Dedicated supportive care team at the oncology unit: a model of simultaneous care for cancer patients
E. Vasile, M. Lucchesi, L. Ginocchi, I. Brunetti +4 more
2014Supportive Care in Cancer8 citations
Semantic Scholar
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
D. Rossini, A. Boccaccino, A. Sbrana, F. Daniel +15 more
2021ESMO Open7 citations Open access
Semantic Scholar
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders.
A. Antonuzzo, F. Calabrò, Pietro Quaglino, F. Roila +16 more
2020The Oncologist7 citations Open access
Semantic Scholar
Supportive care and not only palliative care in the route of cancer patients
A. Antonuzzo, M. Lucchesi, I. Brunetti, L. Galli +4 more
2013Supportive Care in Cancer7 citations
Semantic Scholar
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade
A. Brancatella, L. Pierotti, N. Viola, I. Lupi +12 more
2022European Thyroid Journal6 citations Open access
Semantic Scholar
Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients?
S. Gonella, A. Antonuzzo, P. Bossi
2021Supportive Care in Cancer6 citations
Semantic Scholar
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
P. Bossi, A. Antonuzzo, G. Armento, F. Consoli +6 more
2021Cancer Management and Research5 citations Open access
Semantic Scholar
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
E. Bolzacchini, M. Giordano, L. Bertù, M. Bregni +9 more
2021Tumori5 citations
Semantic Scholar
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study.
E. Bolzacchini, G. Pinotti, L. Bertù, C. Verusio +17 more
2019Clinical Genitourinary Cancer5 citations
Semantic Scholar
Efficacy and safety data from elderly patients with pretreated advanced melanoma in the Italian cohort of ipilimumab expanded access programme (EAP).
V. Chiarion-Sileni, J. Pigozzo, P. Ascierto, M. Maio +16 more
20135 citations
Semantic Scholar
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity
J. Giamello, G. Lauria, A. Antonuzzo, P. Bossi +2 more
2022Supportive Care in Cancer4 citations
Semantic Scholar
Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade
A. Brancatella, I. Lupi, L. Montanelli, D. Ricci +20 more
2021Journal of the Endocrine Society4 citations Open access
Semantic Scholar
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
A. Tralongo, R. Fratamico, C. Russo, A. Sbrana +2 more
2021Geriatrics4 citations Open access
Semantic Scholar
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines
A. Sbrana, A. Antonuzzo, A. Brunello, F. Petrelli +5 more
2020Tumori4 citations
Semantic Scholar
A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma
A. Sbrana, A. Antonuzzo, L. Galli, E. Biasco +3 more
2018Tumori3 citations
Semantic Scholar
NICSO: Network Italiano Cure di Supporto in Oncologia – Italian Network for Supportive Care in Oncology
F. Roila, C. Ripamonti, A. Antonuzzo, P. Bossi
2014Supportive Care in Cancer3 citations
Semantic Scholar
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer
A. Antonuzzo, M. Lucchesi, C. Ripamonti
2023Current Opinion in Oncology2 citations Open access
Semantic Scholar
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
A. Nuzzo, S. Manacorda, E. Sammarco, A. Sbrana +13 more
2022Vaccines2 citations Open access
Semantic Scholar
Efficacy of a nurse monitoring service at preventing disease- or therapy-related symptoms in patients receiving targeted therapy or immunotherapy.
A. Sbrana, A. Antonuzzo, C. Ripamonti, F. Roila +11 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy.
M. Danova, P. Pronzato, Y. Ingrasciotta, A. Antonuzzo +3 more
2020Future Oncology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Sbrana×16
Invite
A. Sbrana — researcher profile on SciRah
P. Bossi×13
Invite
P. Bossi — researcher profile on SciRah
L. Galli×12
Invite
L. Galli — researcher profile on SciRah
A. Falcone×10
Invite
A. Falcone — researcher profile on SciRah

×10

Invite

M. Danova — researcher profile on SciRah

C. Ripamonti×7

Invite

C. Ripamonti — researcher profile on SciRah

Invite

M. Lucchesi — researcher profile on SciRah

Invite

S. Ricci — researcher profile on SciRah

Invite

F. Roila — researcher profile on SciRah

R. Marconcini×5

Invite

R. Marconcini — researcher profile on SciRah

Invite

D. Santini — researcher profile on SciRah

Invite

M. Torchio — researcher profile on SciRah